APTO Aptose Biosciences Inc

Price (delayed)

$4.87

Market cap

$433.15M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.7

Enterprise value

$347.02M

Sector: Healthcare
Industry: Biotechnology

Highlights

The debt has contracted by 33% YoY and by 12% from the previous quarter
The quick ratio has increased by 16% from the previous quarter and by 2.7% YoY
Aptose Biosciences's equity has increased by 25% YoY but it has decreased by 8% QoQ
Aptose Biosciences's net income has plunged by 86% YoY and by 9% from the previous quarter
The EPS has declined by 32% year-on-year and by 4.5% since the previous quarter

Key stats

What are the main financial stats of APTO
Market
Shares outstanding
88.94M
Market cap
$433.15M
Enterprise value
$347.02M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
3.96
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$59.94M
EBITDA
-$59.33M
Free cash flow
-$36.24M
Per share
EPS
-$0.7
Free cash flow per share
-$0.41
Book value per share
$1.23
Revenue per share
$0
TBVPS
$1.3
Balance sheet
Total assets
$115.2M
Total liabilities
$5.79M
Debt
$950,000
Equity
$109.41M
Working capital
$108.78M
Liquidity
Debt to equity
0.01
Current ratio
21.26
Quick ratio
20.88
Net debt/EBITDA
1.45
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-51.9%
Return on equity
-54.9%
Return on invested capital
-281.1%
Return on capital employed
-54.6%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

APTO stock price

How has the Aptose Biosciences stock price performed over time
Intraday
5.41%
1 week
0.41%
1 month
-6.53%
1 year
-36.59%
YTD
11.19%
QTD
-18.56%

Financial performance

How have Aptose Biosciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$60.19M
Net income
-$59.94M
Gross margin
N/A
Net margin
N/A
Aptose Biosciences's net income has plunged by 86% YoY and by 9% from the previous quarter
The company's operating income has shrunk by 82% YoY and by 8% QoQ

Growth

What is Aptose Biosciences's growth rate over time

Valuation

What is Aptose Biosciences stock price valuation
P/E
N/A
P/B
3.96
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has declined by 32% year-on-year and by 4.5% since the previous quarter
Aptose Biosciences's equity has increased by 25% YoY but it has decreased by 8% QoQ
The price to book (P/B) is 18% less than the last 4 quarters average of 4.6 and 6% less than the 5-year quarterly average of 4.0

Efficiency

How efficient is Aptose Biosciences business performance
Aptose Biosciences's ROIC has decreased by 43% YoY and by 16% from the previous quarter
The return on assets has declined by 6% year-on-year and by 3.2% since the previous quarter
APTO's return on equity is down by 3% since the previous quarter and by 3% year-on-year

Dividends

What is APTO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for APTO.

Financial health

How did Aptose Biosciences financials performed over time
The total assets is up by 24% year-on-year but it is down by 9% since the previous quarter
The company's total liabilities fell by 21% QoQ but it rose by 9% YoY
The debt is 99% less than the equity
APTO's debt to equity has dropped by 50% year-on-year
The debt has contracted by 33% YoY and by 12% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.